In order to evaluate the effect of anticancer immune activation induced after NIR-PIT, we performed NIR-PIT using anti-mouse EpCAM as AbPC (mEp-NIR-PIT) against mouse breast cancer models in immunocompetent mice. Here, EPCAM is linked to breast carcinoma.